These authors contributed equally.
Effects of gut microbiota on obesity and atherosclerosis via modulation of inflammation and lipid metabolism
Article first published online: 1 SEP 2010
© 2010 The Association for the Publication of the Journal of Internal Medicine
Journal of Internal Medicine
Volume 268, Issue 4, pages 320–328, October 2010
How to Cite
Caesar, R., Fåk, F. and Bäckhed, F. (2010), Effects of gut microbiota on obesity and atherosclerosis via modulation of inflammation and lipid metabolism. Journal of Internal Medicine, 268: 320–328. doi: 10.1111/j.1365-2796.2010.02270.x
- Issue published online: 1 SEP 2010
- Article first published online: 1 SEP 2010
- Accepted manuscript online: 12 AUG 2010 12:00AM EST
- 1Host-bacterial mutualism in the human intestine. Science 2005; 307: 1915–20., , , , .
- 2Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc Natl Acad Sci U S A 2007; 104: 979–84., , , .
- 3The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci U S A 2004; 101: 15718–23., , et al.
- 4An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006; 444: 1027–31., , , , , .
- 5The gut microbiota modulates host energy and lipid metabolism in mice. J Lipid Res 2010; 51: 1101–12., , et al.
- 6Obesity alters gut microbial ecology. Proc Natl Acad Sci U S A 2005; 102: 11070–5., , , , , .
- 7Microbial ecology:human gut microbes associated with obesity. Nature 2006; 444: 1022–3., , , .
- 8A core gut microbiome in obese and lean twins. Nature 2009; 457: 480–4., , et al.
- 9The role of the gut microbiota in energy metabolism and metabolic disease. Curr Pharm Des 2009; 15: 1546–58., .
- 10Interplay between obesity and associated metabolic disorders: new insights into the gut microbiota. Curr Opin Pharmacol 2009; 9: 737–43., .
- 11Gut microbiota as a regulator of energy homeostasis and ectopic fat deposition: mechanisms and implications for metabolic disorders. Curr Opin Lipidol 2010; 21: 76–83., , .
- 12The core gut microbiome, energy balance and obesity. J Physiol 2009; 587: 4153–8., .
- 13The environment within: how gut microbiota may influence metabolism and body composition. Diabetologia 2010; 53: 606–13., , , , , .
- 14Coordinated regulation of the metabolome and lipidome at the host-microbial interface. Biochim Biophys Acta 2010; 1801: 240–5., .
- 15Intestinal microbiota during infancy and its implications for obesity. J Pediatr Gastroenterol Nutr 2009; 48: 249–56., , .
- 16Pathogen recognition and innate immunity. Cell 2006; 124: 783–801., , .
- 17Inferences, questions and possibilities in toll-like receptor signalling. Nature 2004; 430: 257–63..
- 18Toll-like receptors in systemic autoimmune disease. Nat Rev Immunol 2006; 6: 823–35..
- 19Nutrient sensing and inflammation in metabolic diseases. Nat Rev Immunol 2008; 8: 923–34., .
- 20A genetic basis for the “Adonis” phenotype of low adiposity and strong bones. FASEB J 2004; 18: 1282–4., , .
- 21Loss-of-function mutation in toll-like receptor 4 prevents diet-induced obesity and insulin resistance. Diabetes 2007; 56: 1986–98., , et al.
- 22Hematopoietic cell-specific deletion of toll-like receptor 4 ameliorates hepatic and adipose tissue insulin resistance in high-fat-fed mice. Cell Metab 2009; 10: 419–29., , et al.
- 23Metabolic syndrome and altered gut microbiota in mice lacking toll-like receptor 5. Science 2010; 328: 228–31., , et al.
- 24Inflammation, stress, and diabetes. J Clin Invest 2005; 115: 1111–9., .
- 25The indigenous gastrointestinal microflora. Trends Microbiol 1996; 4: 430–5..
- 26Endotoxin levels in sera of elderly individuals. Clin Diagn Lab Immunol 1994; 1: 684–8., , , , , .
- 27Association of endotoxemia with carotid atherosclerosis and cardiovascular disease: prospective results from the bruneck study. J Am Coll Cardiol 1999; 34: 1975–81., , et al.
- 28Endotoxin release and endotoxin neutralizing capacity during colonoscopy. Clin Chim Acta 2001; 303: 49–53., , , , , .
- 29Endotoxin and immune activation in chronic heart failure: a prospective cohort study. Lancet 1999; 353: 1838–42., , et al.
- 30Plasma endotoxin level of healthy donors. Acta Microbiol Immunol Hung 2002; 49: 151–7., , , .
- 31Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes. Am J Physiol Endocrinol Metab 2007; 292: E740–7., , et al.
- 32Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007; 56: 1761–72., , et al.
- 33Regulation of serum amyloid A3 (SAA3) in mouse colonic epithelium and adipose tissue by the intestinal microbiota. PLoS ONE 2009; 4: e5842., , , .
- 34Toll-like receptor 4 resides in the golgi apparatus and colocalizes with internalized lipopolysaccharide in intestinal epithelial cells. J Exp Med 2002; 195: 559–70., , , , .
- 35Electron microscopic studies of the assembly, intracellular transport, and secretion of chylomicrons by rat intestine. J Lipid Res 1977; 18: 496–511., .
- 36Chylomicrons promote intestinal absorption of lipopolysaccharides. J Lipid Res 2009; 50: 90–7., , , , .
- 37A high-fat meal induces low-grade endotoxemia: evidence of a novel mechanism of postprandial inflammation. Am J Clin Nutr 2007; 86: 1286–92., , , .
- 38Energy intake is associated with endotoxemia in apparently healthy men. Am J Clin Nutr 2008; 87: 1219–23., , et al.
- 39Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis. Am J Physiol Gastrointest Liver Physiol 2007; 292: G518–25., , et al.
- 40Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet–induced obesity and diabetes in mice. Diabetes 2008; 57: 1470–81., , et al.
- 41Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia 2007; 50: 2374–83., , et al.
- 42Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 2009; 58: 1091–103., , et al.
- 43Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J Lipid Res 2005; 46: 2347–55., , et al.
- 44Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest 2007; 117: 175–84., , .
- 45Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003; 112: 1796–808., , , , , .
- 46Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 2003; 112: 1821–30., , et al.
- 47Dietary intake, energy metabolism, and excretory losses of adult male germfree Wistar rats. Lab Anim Sci 1983; 33: 46–50., , , .
- 48TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 2006; 116: 3015–25., , , , , .
- 49A subpopulation of macrophages infiltrates hypertrophic adipose tissue and is activated by free fatty acids via toll-like receptors 2 and 4 and JNK-dependent pathways. J Biol Chem 2007; 282: 35279–92., , et al.
- 50Role of the toll-like receptor 4/NF-kappaB pathway in saturated fatty acid-induced inflammatory changes in the interaction between adipocytes and macrophages. Arterioscler Thromb Vasc Biol 2007; 27: 84–91., , et al.
- 51Serine phosphorylation of insulin receptor substrate 1 by inhibitor κB kinase complex. J Biol Chem 2002; 277: 48115–21., , et al.
- 52The c-Jun NH2-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser307. J Biol Chem 2000; 275: 9047–54., , , , .
- 53IKK-beta links inflammation to obesity-induced insulin resistance. Nat Med 2005; 11: 191–8., , et al.
- 54JNK1 in hematopoietically derived cells contributes to diet-induced inflammation and insulin resistance without affecting obesity. Cell Metab 2007; 6: 386–97., , et al.
- 55Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunity. Nat Med 2010; 16: 228–31., , , , , .
- 56Toll-like receptor-2 mediates inflammation and matrix degradation in human atherosclerosis. Circulation 2009; 120: 2462–9., , , , , .
- 57Toll-like receptor 4 polymorphisms and atherogenesis. N Engl J Med 2002; 347: 185–92., , et al.
- 58Lack of toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. Proc Natl Acad Sci U S A 2004; 101: 10679–84., , et al.
- 59Modulation of atherosclerosis in mice by toll-like receptor 2. J Clin Invest 2005; 115: 3149–56., , .
- 60Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways. Nat Med 2004; 10: 416–21., , et al.
- 61HDL, ABC transporters, and cholesterol efflux: implications for the treatment of atherosclerosis. Cell Metab 2008; 7: 365–75., , , , .
- 62The liver X receptor gene team: potential new players in atherosclerosis. Nat Med 2002; 8: 1243–8., .
- 63Crosstalk between LXR and toll-like receptor signaling mediates bacterial and viral antagonism of cholesterol metabolism. Mol Cell 2003; 12: 805–16., , et al.
- 64Myeloid differentiation primary response protein 88 couples reverse cholesterol transport to inflammation. Cell Metab 2010; 11: 493–502., , et al.
- 65Infection and atherosclerosis: potential roles of pathogen burden and molecular mimicry. Arterioscler Thromb Vasc Biol 2000; 20: 1417–20., , , , , .
- 66Periodontal microbiota and carotid intima-media thickness: the Oral Infections and Vascular Disease Epidemiology Study (INVEST). Circulation 2005; 111: 576–82., , et al.
- 67Chlamydia pneumoniae induces macrophage-derived foam cell formation via PPAR a and PPAR g-dependent pathways. Cell Biol Int 2009; 33: 301–8., , , , , .
- 68Detection of diverse bacterial signatures in atherosclerotic lesions of patients with coronary heart disease. Circulation 2006; 113: 929–37., , et al.
- 69Chlamydia pneumoniae-induced foam cell formation requires MyD88-dependent and -independent signaling and is reciprocally modulated by liver X receptor activation. J Immunol 2008; 181: 7186–93., , et al.
- 70Anti-chlamydial antibiotic therapy for symptom improvement in peripheral artery disease: prospective evaluation of rifalazil effect on vascular symptoms of intermittent claudication and other endpoints in Chlamydia pneumoniae seropositive patients (PROVIDENCE-1). Circulation 2009; 119: 452–8., , et al.
- 71Effects of antibiotic therapy on outcomes of patients with coronary artery disease: a meta-analysis of randomized controlled trials. JAMA 2005; 293: 2641–7., , .
- 72Antibiotic treatment of atherosclerosis. Curr Opin Lipidol 2003; 14: 605–14..
- 73Association between dental health and acute myocardial infarction. BMJ 1989; 298: 779–81., , et al.
- 74Identification of periodontal pathogens in atheromatous plaques. J Periodontol 2000; 71: 1554–60., , , , .
- 75Human atherosclerotic plaque contains viable invasive Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis. Arterioscler Thromb Vasc Biol 2005; 25: e17–8., , , , .
- 76Detection of Porphyromonas gingivalis DNA in aortic tissue by PCR. J Periodontol 2002; 73: 868–70., , et al.
- 77Quantitative detection of periodontopathic bacteria in atherosclerotic plaques from coronary arteries. J Med Microbiol 2009; 58: 1568–75., , , , .
- 78Innate immune recognition of invasive bacteria accelerates atherosclerosis in apolipoprotein E-deficient mice. Circulation 2004; 109: 2801–6., , et al.
- 79Toothbrushing, inflammation, and risk of cardiovascular disease: results from Scottish Health Survey. BMJ 2010; 340: c2451., , .
- 80C-reactive protein levels and outcomes after statin therapy. N Engl J Med 2005; 352: 20–8., , et al.
- 81Absence of microbiota (germ-free conditions) accelerates the atherosclerosis in ApoE-deficient mice fed standard low cholesterol diet. J Atheroscler Thromb 2010; Apr 2 (Epub ahead of print)., , et al.
- 82Infectious agents are not necessary for murine atherogenesis. J Exp Med 2000; 191: 1437–42., , et al.
- 83Effect of Lactobacillus reuteri on the prevention of hypercholesterolemia in mice. J Dairy Sci 2000; 83: 401–3., , , , .
- 84Effect of fermented milk containing Lactobacillus acidophilus and Bifidobacterium longum on plasma lipids of women with normal or moderately elevated cholesterol. J Dairy Sci 2009; 76: 469–74., .
- 85The impact of perinatal probiotic intervention on the development of overweight and obesity: follow-up study from birth to 10 years. Int J Obes (Lond) 2010; Mar 16 (Epub ahead of print)., , , .
- 86Regulation of abdominal adiposity by probiotics (Lactobacillus gasseri SBT2055) in adults with obese tendencies in a randomized controlled trial. Eur J Clin Nutr 2010; 64: 636–43., , et al.
- 87Effect of Lactobacillus delbrueckii on cholesterol metabolism in germ-free mice and on atherogenesis in apolipoprotein E knock-out mice. Braz J Med Biol Res 2006; 39: 629–35., , et al.
- 88Inulin attenuates atherosclerosis in apolipoprotein E-deficient mice. Br J Nutr 2006; 96: 840–4., , , , , .
- 89Effects of probiotic bacteria, isoflavones and simvastatin on lipid profile and atherosclerosis in cholesterol-fed rabbits: a randomized double-blind study. Lipids Health Dis 2009; 8: doi:10.1186/476-511X-8-1., , , , .
- 90Effect of Lactobacillus plantarum 299v on cardiovascular disease risk factors in smokers. Am J Clin Nutr 2002; 76: 1249–55., , , .
- 91Obesity and the human microbiome. Curr Opin Gastroenterol 2010; 26: 5–11..